Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol Methods ; 496: 113088, 2021 09.
Article in English | MEDLINE | ID: mdl-34181967

ABSTRACT

Blue eye disease (BED) of pigs was identified in the early 1980s in La Piedad, Michoacan, Mexico. The causal agent is Porcine orthorubulavirus (PRV), which affects pigs of all ages, producing nervous, respiratory, and reproductive disorders. BED is geographically endemic to the center of Mexico, where 75% of the country's swine industry is concentrated. Due to its adverse effects on the swine industry and the risk of dissemination to other countries, it is essential to have reliable diagnostic methods for BED. The objective of this study was to establish the optimal conditions for three serological tests, hemagglutination inhibition (HI), immunoperoxidase monolayer assay (IPMA), and serum neutralization (SN), and to compare their sensitivity, specificity, kappa coefficient, and predictive values. Twelve different HI protocols (9408 tests), one SN protocol and one IPMA protocol (784 tests, each) were evaluated. Forty-nine sera were analyzed, and thirty-seven sera showed true positive results, while twelve showed true negative results. The kappa coefficient was used to assess the variation in each test. The best HI protocol registered a sensitivity and specificity of 89 and 100%, respectively, the IPMA test showed values of 85 and 100%, and the SN test registered a sensitivity of 91% and a specificity of 96%. One of the disadvantages of the HI test is that when chicken red blood cells (RBCs) are used, elution occurs in a short incubation time, which would decrease the specificity. The use of bovine RBCs increases the specificity of the testy and makes it more stable, but it decreases the sensitivity. The results of HI and SN revealed the importance of eliminating the complement system of the serum and removing other inhibitors to avoid test nonspecificity. The IPMA test does not use an active virus; hence, it is considered safe and does not present any risk of disseminating PRV.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Eye Infections, Viral/diagnosis , Hemagglutination Inhibition Tests/veterinary , Immunoenzyme Techniques/veterinary , Rubulavirus Infections/diagnosis , Rubulavirus/immunology , Serologic Tests/veterinary , Swine Diseases/diagnosis , Animals , Biomarkers/blood , Eye Infections, Viral/blood , Eye Infections, Viral/immunology , Eye Infections, Viral/virology , Hemagglutination Inhibition Tests/standards , Immunoenzyme Techniques/standards , Mexico , Predictive Value of Tests , Reproducibility of Results , Rubulavirus Infections/blood , Rubulavirus Infections/immunology , Rubulavirus Infections/virology , Serologic Tests/standards , Swine , Swine Diseases/blood , Swine Diseases/immunology , Swine Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...